Interference of progestins with endothelial actions of estrogens: a matter of glucocorticoid action or deprivation?
Arnal
J F
JF
Gourdy
P
P
Simoncini
T
T
D000818:Animals; D002478:Cells, Cultured; D003327:Coronary Disease / Q000209:etiology / Q000378:metabolism; D042783:Endothelial Cells / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism; D004958:Estradiol / Q000378:metabolism*; D015914:Estrogen Replacement Therapy / Q000009:adverse effects; D005260:Female; D005938:Glucocorticoids / Q000378:metabolism*; D006801:Humans; D009569:Nitric Oxide / Q000378:metabolism; D052250:Nitric Oxide Synthase Type III / Q000378:metabolism; D010974:Platelet Aggregation / Q000187:drug effects; D011374:Progesterone / Q000378:metabolism*; D045167:Progesterone Congeners / Q000009:adverse effects / Q000494:pharmacology*; D016032:Randomized Controlled Trials as Topic; D011965:Receptors, Glucocorticoid / Q000378:metabolism; D011980:Receptors, Progesterone / Q000378:metabolism; D013927:Thrombosis / Q000209:etiology / Q000378:metabolism; D016387:Women's Health
D005938:Glucocorticoids; D045167:Progesterone Congeners; D011965:Receptors, Glucocorticoid; D011980:Receptors, Progesterone; D009569:Nitric Oxide; D011374:Progesterone; D004958:Estradiol; C496314:NOS3 protein, human; D052250:Nitric Oxide Synthase Type III